Citizens Financial Group’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-4,332
Closed -$134K – 681
2020
Q2
$134K Buy
4,332
+457
+12% +$12.7K 0.01% 325
2020
Q1
$107K Buy
+3,875
New +$116K 0.01% 324

Other funds holding NEO

Citizens Financial Group's NEO Position: Q3 2020 in Review

Citizens Financial Group sold out of NeoGenomics (NEO) in Q3 2020, closing a stake of 4,332 shares — an estimated $134K sold.

Citizens Financial Group first reported a position in NEO in Q1 2020 and held it in 2 quarters. The position peaked at $134K in Q2 2020. 294 funds tracked by Wall St. Rank hold NEO as of Q3 2020.

  • Citizens Financial Group reported no remaining NeoGenomics position as of Q3 2020 after selling out during the quarter.
  • Citizens Financial Group sold 4,332 NeoGenomics shares in Q3 2020, an estimated $134K.
  • Citizens Financial Group first reported a position in NeoGenomics in Q1 2020 and held it in 2 quarters.
  • Citizens Financial Group's NeoGenomics position peaked at $134K in Q2 2020.
  • 294 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2020.

Based on Citizens Financial Group's 13F filing for Q3 2020, filed 12 Nov 2020.